CELLDEX THERAPEUTICS INC NEW's ticker is and the CUSIP is 15117B953. A total of 2 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $662,000 | -17.6% | 150,900 | -29.0% | 0.00% | 0.0% |
| Q1 2016 | $803,000 | -47.4% | 212,500 | +118.4% | 0.00% | -50.0% |
| Q4 2015 | $1,526,000 | +30.8% | 97,300 | -12.1% | 0.00% | +100.0% |
| Q3 2015 | $1,167,000 | -40.5% | 110,700 | +42.5% | 0.00% | -50.0% |
| Q2 2015 | $1,960,000 | -52.3% | 77,700 | -47.3% | 0.00% | -50.0% |
| Q1 2015 | $4,105,000 | +92.7% | 147,300 | +26.2% | 0.00% | +100.0% |
| Q4 2014 | $2,130,000 | +44.3% | 116,700 | +2.5% | 0.00% | 0.0% |
| Q3 2014 | $1,476,000 | +33.0% | 113,900 | +67.5% | 0.00% | +100.0% |
| Q2 2014 | $1,110,000 | -35.5% | 68,000 | -30.2% | 0.00% | -50.0% |
| Q1 2014 | $1,721,000 | -15.1% | 97,400 | +16.4% | 0.00% | -33.3% |
| Q4 2013 | $2,026,000 | -14.5% | 83,700 | +25.1% | 0.00% | -25.0% |
| Q3 2013 | $2,370,000 | +448.6% | 66,900 | +141.5% | 0.00% | +300.0% |
| Q2 2013 | $432,000 | – | 27,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 92,800 | $1,449,000 | 0.04% |
| Citadel Advisors | 27,700 | $432,000 | 0.00% |